A key step towards reducing the burden of central nervous system (CNS) disorders is the identification of disease-specific biomarkers that can help predict, monitor, and guide treatment development.
In today's world, Hari Suresh Babu Gummadi, a researcher focused on medical technology innovation, presents a transformative solution in his latest work on multimodal AI for personalized healthcare.
Association of early tumor growth rate and survival outcomes in first-line metastatic non–small cell lung cancer (mNSCLC). This is an ASCO Meeting Abstract from the 2022 ASCO Annual Meeting I. This ...
The field of regulatory genomics has evolved rapidly, with increasing complexity in understanding how genes are regulated within the three-dimensional ...
Anyscale, founded by the creators of Ray, today announced upcoming new capabilities in Ray and the Anyscale platform designed to help teams build and deploy AI workloads at production scale. As more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results